Bryan Garnier

Since 1996, Bryan, Garnier & Co has been growing with an absolute conviction that the investment banking landscape would experience a major revolution: most of the large local generalist banking groups will disappear to the benefit of a handful of global powerhouses, and an emerging group of independent, highly specialised boutique investment banks.

Ingird Gafanhão
  • Ingird Gafanhão

In a prime position to execute or to be acquired

The first data presented for all adult r/r ALL patients treated in the FELIX phase 2 trial was positively straightforward with i) consistent response rates that compare well to competing therapies, ii) outstanding safety which is superior to competing therapies, and iii) industry standard ability t

Alex Cogut ... (+3)
  • Alex Cogut
  • Ingird Gafanhão
  • Oscar Haffen Lamm

KOL dinner with Dr Bruce Levine: improved access to cell therapies is ...

We hosted a KOL dinner with Dr Bruce Levine in the context of the International Society for Cell & Gene Therapy (ISCT) conference in Paris. The discussion focused on a few clear points i) to understand a cell product, you need to understand the process, and ii) broader access to cell therapies

Paul de Froment
  • Paul de Froment

End of coverage

From 2nd of June 2023, we will no longer include:HDF in our coverage universe.

Paul de Froment ... (+2)
  • Paul de Froment
  • Thomas Mordelle

Groundbreaking collaboration with Indorama Ventures

Carbios and Indorama Ventures have reaffirmed their partnership through a non-binding Memorandum of Understanding (MOU) to establish a Joint Venture for the construction of the world's first PET biorecycling plant, namely the Reference Unit, in Longlaville (France). While Carbios' investment detail

Thomas Coudry
  • Thomas Coudry

End of coverage

From 2nd of June 2023, we will no longer include:Technicholor Creative Studios in our coverage universe.

Gregory Ramirez
  • Gregory Ramirez

LECTRA BUY | EUR45 Good resistance Chinese lockdowns; strong orde...

º Q2 results were slightly below expectations, but remained decent despite lockdowns in China New system orders hold up well thanks to automotive Company guidance for 2022 has been tightened toward its mid-point

Thibault Morel
  • Thibault Morel

HMS NETWORKS: HMS Networks 2Q22 results above expectations | CONVICTIO...

HMS NETWORKS - CONVICTION BUY | SEK500 HMS Networks 2Q22 results above expectations 2Q22 sales and new orders above expectations Positive surprise on 2Q22 profitability

Cedric Rossi
  • Cedric Rossi

HUGO BOSS: Successful execution and healthy geo mix lead to raised FY2...

HUGO BOSS - NEUTRAL | EUR68 vs. EUR64 Successful execution and healthy geo mix lead to raised FY22 guidance Strong sales and EBIT beat in Q2 driven by execution… … and low exposure to China’s lockdowns FY22 sales and EBIT guidance revised upwards and we increase our FY22-23 estimates by 7%

Clement Genelot
  • Clement Genelot

ROCHE BOBOIS: Q4 topping expectations with good H1 2022 prospects

ROCHE BOBOIS: Q4 topping expectations with good H1 2022 prospects

Victor Floc’h
  • Victor Floc’h

ONCODESIGN (CORPORATE, TP EUR15) | R&D collaboration signed with TiumB...

ONCODESIGN (CORPORATE, TP EUR15) | R&D collaboration signed with TiumBio in fibrosis

ResearchPool Subscriptions

Get the most out of your insights

Get in touch